Evidence map›Paper›PMID 32454943›Full record

ArticleOxidative medicine and cellular longevity2020

The Protective Effects of Imperatorin on Acetaminophen Overdose-Induced Acute Liver Injury.

Zhao Gao, Jiecheng Zhang, Li Wei, Xingping Yang, Yuan Zhang, Bo Cheng, Zehong Yang, Weihang Gao, Chunhui Song, Wei Miao and 5 more

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Oxidative medicine and cellular longevity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Water Extract ofInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Farnesoid X receptor regulators from natural products and their biological function.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. TheFrontiers in pharmacology · 2022
    Review
  14. Hepatoprotection ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 2 countries.

Zhao GaoArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jiecheng ZhangDepartment of Surgery, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Li WeiThe Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Xingping YangThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.
Yuan ZhangGuangdong Institute of Sports Science, Guangzhou, China.
Bo ChengScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Zehong YangScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Weihang GaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Chunhui SongScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Wei MiaoScience and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Kevin WilliamsDivision of Hypothalamic Research, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Changhui LiuSchool of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0001-6165-4313
Qin XuArtemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.ORCID https://orcid.org/0000-0002-2146-7342
Yongsheng ChangTianjin Key Laboratory of Cellular and Molecular Immunology, Key Laboratory of Immune Micro-Environment and Disease (Ministry of Education), Department of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.ORCID https://orcid.org/0000-0002-7846-8127
Yong GaoThe First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, China.ORCID https://orcid.org/0000-0002-7795-3649
Guangzhou University of Chinese Medicine · CNFirst Affiliated Hospital of Guangdong Pharmaceutical University · CNThe University of Texas Southwestern Medical Center · USTianjin Medical University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetaminophen (APAP) toxicity leads to severe acute liver injury (ALI) by inducing excessive oxidative stress, inflammatory response, and hepatocyte apoptosis. Imperatorin (IMP) is a furanocoumarin from Angelica dahurica, which has antioxidant and anti-inflammatory effects. However, its potential to ameliorate ALI is unknown. In this study, APAP-treated genetic knockout of Farnesoid X receptor (FXR) and Sirtuin 1 (SIRT1) mice were used for research. The results revealed that IMP could improve the severity of liver injury and inhibit the increase of proinflammatory cytokines, oxidative damage, and apoptosis induced by overdose APAP in an FXR-dependent manner. We also found that IMP enhanced the activation and translocation of FXR by increasing the expression of SIRT1 and the phosphorylation of AMPK. Besides, single administration of IMP at 4 h after APAP injection can also improve necrotic areas and serum transaminase, indicating that IMP have both preventive and therapeutic effects. Taken together, it is the first time to demonstrate that IMP exerts protective effects against APAP overdose-induced hepatotoxicity by stimulating the SIRT1-FXR pathway. These findings suggest that IMP is a potential therapeutic candidate for ALI, offering promise for the treatment of hepatotoxicity associated with APAP overdose.

Indexed as

AcetaminophenAcute DiseaseAnimalsAntioxidantsCytokinesDrug OverdoseFurocoumarinsGene Expression RegulationHepatocytesInflammation MediatorsLipopolysaccharidesLiverMaleMice, Inbred C57BLMice, KnockoutMitochondriaAcetaminophenAntioxidantsCytokinesFurocoumarinsimperatorinInflammation MediatorsLipopolysaccharidesProtective AgentsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearSirtuin 1

Identifiers

PMID32454943
PMCPMC7243017
OpenAlexW3024048982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.